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Abtract 21 
Brain computations rely on a proper balance between excitation and inhibition which 22 
progressively emerges during postnatal development in rodent. -aminobutyric acid (GABA) 23 
neurotransmission supports inhibition in the adult brain but excites immature rodent neurons. 24 
Alterations in the timing of the GABA switch contribute to neurological disorders, so 25 
unveiling the involved regulators may be a promising strategy for treatment. Here we show 26 
that the adipocyte hormone leptin sets the tempo for the emergence of GABAergic inhibition 27 
in the newborn rodent hippocampus. In the absence of leptin signaling, hippocampal neurons 28 
show an advanced emergence of GABAergic inhibition. Conversely, maternal obesity 29 
associated with hyperleptinemia delays the excitatory to inhibitory switch of GABA action in 30 
offspring. This study uncovers a developmental function of leptin that may be linked to the 31 
pathogenesis of neurological disorders and helps understanding how maternal environment 32 
can adversely impact offspring brain development. 33 
 34 
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Introduction 36 
Most brain computations rely on a proper balance between excitation and inhibition, 37 
which progressively emerges during development. The -aminobutyric acid (GABA) is the 38 
main inhibitory transmitter in the adult brain. However, in rodents, at fetal and postnatal 39 
stages, GABA induces a membrane depolarization due to elevated intracellular chloride 40 
concentration ([Cl
-
]i) (Ben Ari et al., 2007; Sato et al., 2017; Owens and Kriegstein, 2002). 41 
During the second postnatal week of life, the functional expression of the chloride extruder, 42 
K
+
-Cl
-
 type 2 co-transporter (KCC2), causes [Cl
-
]i to decrease and consequently shifts the 43 
chloride-dependent GABAergic responses towards a more hyperpolarized value (Rivera et al., 44 
1999). This developmental sequence is likely shifted toward fetal life in humans (Chen and 45 
Kriegstein, 2015; Sedmak et al., 2016). Rodent studies showed that defective chloride 46 
homeostasis plays a role in phenotypes associated with autism spectrum disorders (ASD) 47 
(Tyzio et al., 2014; He et al., 2014), Rett syndrome (Banerjee et al., 2016; El-Khoury et al., 48 
2014), Down syndrome (Deidda et al., 2015) and Huntington’s disease (Dargaei et al., 2018). 49 
Conversely, pharmacological manipulations aimed at restoring low [Cl
-
]i improve 50 
neurological symptoms in rodents (Tyzio et al., 2014; Deidda et al., 2015; Banerjee et al., 51 
2016; Dargaei et al., 2018) and humans (Lemonnier et al., 2017). Therefore, unveiling the 52 
mechanisms controlling the schedule of the GABA developmental sequence is decisive to 53 
identify molecular targets to correct abnormal developmental trajectories. 54 
Leptin is a 16kDa cytokine produced and secreted mainly by the adipose tissue. In the 55 
adult, leptin regulates body weight and reproduction acting on specific hypothalamic nuclei 56 
(Ahima and Flier, 2000). However, rodent studies show that leptin can act beyond this 57 
classical role and may function as a neurotrophic signal (Bouret et al., 2004; Harvey, 2013; 58 
Guimond et al., 2014; Briffa et al., 2015). In both humans and rodents leptin levels surge 59 
during intense period of neuronal growth and synaptogenesis. Leptin levels remain elevated in 60 
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children with early onset ASD (Rodrigues et al., 2014), Rett syndrome (Blardi et al., 2009) 61 
and Fragile X syndrome (Lisik et al., 2016). Likewise, maternal obesity which is associated 62 
with hyperleptinemia heightens the risk of ASD and other neuropsychiatric disorders in 63 
children (Wang et al., 2016; Rivera et al., 2015). These observations suggest that excess leptin 64 
early in life may play a role in neuropsychiatric disorders in humans. 65 
Here we examined how leptin impacts the GABAergic developmental sequence in the 66 
rodent hippocampus. We provide evidence that leptin controls the depolarizing-to-67 
hyperpolarizing GABA switch during postnatal development and that maternal obesity 68 
associated with hyperleptinemia delays the GABA switch in offspring. 69 
 70 
  71 
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Results 72 
Advanced onset of GABAergic inhibition in leptin-receptor deficient mice 73 
We first compared the efficacy of GABAA receptor signaling in newborn long-form 74 
leptin-receptor (LepRb, the only leptin receptor able to activate intracellular pathway (Ahima 75 
and Flier, 2000) deficient (db/db) and wild type (wt) mice. To this aim we obtained non-76 
invasive loose cell attached recordings of CA3 pyramidal neurons in acute hippocampal slices 77 
from db/db and wt littermates and investigated the effect of bath application of the GABAA 78 
receptor agonist isoguvacine (10µM, 2 min) on their neuronal firing (Figure 1A). Consistent 79 
with the known depolarizing action of GABA in the newborn hippocampus (Ben Ari et al., 80 
2007), isoguvacine increased the firing of wt CA3 pyramidal neurons from P1 to P6 (Fig. 1 81 
B). Remarkably, in db/db mice, the excitatory action of isoguvacine was only observed at P1 82 
(Figure 1B). As early as P3, isoguvacine decreased the firing of the CA3 pyramidal db/db 83 
neurons (Figure 1B). At P15, the effect of isoguvacine on the firing of the CA3 pyramidal 84 
neurons was similar in wt and db/db mice (Figure 1B). Next to determine whether the 85 
depolarizing-to-hyperpolarizing GABA developmental sequence was affected, we 86 
investigated the reversal potential of evoked GABAA receptor-mediated postsynaptic currents 87 
(eGABAA-PSCs) in db/db and wt littermates from P1 to P20 using gramicidin perforated 88 
voltage-clamp recording to prevent disruption of intracellular chloride concentration ([Cl
-
]i). 89 
GABAA-PSCs were evoked in the presence of the glutamatergic receptor antagonists; NBQX 90 
(5µM) and D-APV (40µM) while voltage clamping the neurons at various potentials (Figure 91 
1C). In wt CA3 neurons, the reversal potential of eGABAA-PSCs (EGABA) shifted from 92 
depolarizing to hyperpolarizing values during the second postnatal week of life (Fig. 1 D). In 93 
db/db neurons, this shift occurred earlier, few days after birth (Figure 1D, at P3 EGABA was -94 
38+8 mV in wt and -64+3 mV in db/db neurons, P=0.023, two-tailed unpaired Student’s t-95 
test). In contrast the membrane potential at zero current was similar between wt and db/db 96 
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neurons at all age investigated (Figure 1D). Altogether, these data show that the emergence of 97 
GABAergic inhibition is advanced in leptin-receptor deficient mice in vivo. 98 
 99 
 100 
Figure 1: Early GABA developmental sequence in leptin-receptor deficient mice. 101 
(A) Cell attached recordings of CA3 pyramidal neurons on acute hippocampal slices. Scale bar, 2 min, 50pA. 102 
Corresponding time course of spike frequency changes are shown under each trace. (B) Developmental changes 103 
of isoguvacine action on spike activity. Mean+SEM. (C) Current-voltage relationships for evoked GABAergic 104 
synaptic currents. Insets : examples of GABAergic synaptic current evoked at holding potentials ranging from -105 
110 to -60 mV (10 mV increment) in db/db and from -70 to -30 (10 mV increment) in wt CA3 pyramidal neuron. 106 
Scale bar, 10 ms, 20pA. (D) Developmental changes in EGABA and Em at zero current. Mean+SEM. In B and D, 107 
the number of cells recorded and number of mice used are indicated in parenthesis; #P<0.05 when compared to 108 
pre-isoguvacine values, two-tailed paired Student’s t-test, *P<0.05, **P<0.01  and ***P<0.001 when compared 109 
to age matched wt, two-tailed unpaired Student’s t-test. (E) Developmental profile of plasma leptin levels in the 110 
wt (blue circle) and developmental profile of EGABA (gray circle). EGABA was calculated as the difference in 111 
EGABA values between the wt and db/db at each developmental stage depicted in D. Numbers in parenthesis 112 
indicate the number of mice used. Mean + SEM. §P<0.05 when compared to P0 plasma leptin values, *P<0.05 113 
and **P<0.01 when compared to P0 EGABA values, one way ANOVA followed by a Tukey’s post hoc test.  (F) 114 
Left: representative immuno-blots for hippocampal panKCC2 and 3-tubulin in wt and db/db mice (first two 115 
lanes). The third lane (-) illustrates background (empty well). Right: box plots of normalized pan KCC2 in P6 wt 116 
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and db/db hippocampi. Numbers in parenthesis indicate the number of mice used. *P<0.05, two-tailed unpaired 117 
Student’s t-test.  118 
 119 
To further link leptin with the GABA sequence, we investigated the developmental 120 
profile of plasma leptin levels in wt mice. We found that circulating leptin levels were low at 121 
birth in wt, rose to a peak by the end of the first postnatal week and declined to low levels 122 
during the third postnatal week of life (Figure 1E). Interestingly, this developmental profile of 123 
leptin levels paralleled the developmental difference in EGABA observed between wt and db/db 124 
neurons (Figure 1D,E). Therefore, leptin levels surge during a critical developmental window 125 
in wt mice, and EGABA is impaired during this critical window in db/db mice. However 126 
correlation does not mean causality. To address this point we used, newborn leptin-deficient 127 
(ob/ob) mice. We found that ob/ob mice also exhibit an advanced emergence of GABAergic 128 
inhibition in vivo, an effect partially restored by subcutaneous recombinant leptin injections to 129 
mimic the leptin surge occurring in wt mice in vivo (Figure 1-figure supplement 1). 130 
Altogether, these data show that leptin surge controls chloride homeostasis and the emergence 131 
of functional GABAergic inhibition in vivo. 132 
The developmental switch in GABA polarity is mainly due to the functional 133 
expression of KCC2 (Medina et al., 2014; Rivera et al., 1999). We therefore assessed mRNA 134 
expression of this Cl
- 
co-transporter in wt and db/db mice at P6 using quantitative qRT-PCR 135 
from isolated hippocampi. KCC2 mRNA levels were enhanced in db/db hippocampi 136 
compared to wt (from 1.6+0.1 in wt to 2.6+0.3 in db/db mice, n=6 for both, P=0.038, two-137 
tailed unpaired Student’s t-test, not shown). In contrast, NKCC1 mRNA levels were not 138 
altered (1.1+0.2 and 1.2+0.2 in respectively wt and db/db mice, n=6 for both, P=0.7, two-139 
tailed unpaired Student’s t-test, not shown). To determine whether increased mRNA levels 140 
results in increased expression of KCC2, we assessed KCC2 protein levels in P6 hippocampi 141 
by western blotting. KCC2 protein expression was up-regulated in db/db hippocampi 142 
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compared to wt (+33+6 %, n=6 wt and 5 db/db hippocampi, P=0.02 two-tailed unpaired 143 
Student’s t-test, Figure 3F). Immuno-labeling confirmed that KCC2 protein expression was 144 
up-regulated in db/db hippocampi at P6 compared to wt (Figure 1-figure supplement 2). 145 
KCC2 expression was also up-regulated in ob/ob hippocampi compared to wt (from 146 
0.38+0.07 to 0.97+0.24 when normalized to 3 tubulin, n=6 for both, P=0.04, two-tailed 147 
unpaired Student’s t-test, not shown). NKCC1 expression was however similar between wt 148 
and db/db neurons (the NKCC1/3 tubulin ratio was 0.56+0.01 and 0.55+0.02 in respectively 149 
wt (n=3) and db/db (n=3) mice, P=0.8 two-tailed unpaired Student’s t-test, Supplementary 150 
File 1). Thus a deficit in leptin signaling leads to an earlier expression of KCC2 and an 151 
advanced GABA switch to inhibition in vivo. 152 
 153 
Leptin controls chloride homeostasis in vitro. 154 
We next asked whether leptin directly acts on hippocampal cells to control Cl
-
 155 
homeostasis. To address this point, we first evaluated the effect of a transient exposure to 156 
leptin (100 nM, 24h) on Cl
-
 homeostasis on hippocampal cultures in immature neurons (6 157 
DIV) when KCC2 activity is low, and in more mature neurons (15 DIV) when KCC2 activity 158 
is high and GABA had switched to hyperpolarized values (Friedel et al., 2015). Using 159 
gramicidin perforated voltage-clamp recordings; we assessed the reversal potential of GABAA 160 
receptor-mediated currents (EGABA) induced by brief focal applications of isoguvacine in the 161 
presence of the NKCC1 blocker bumetanide (10µM), to exclude cross regulation between the 162 
2 co-transporters. We found that leptin treatment had no effect on EGABA in immature neurons 163 
(EGABA = -61+1 in control (19 neurons) and -61+2 mV in leptin-treated (19 neurons) cultures, 164 
3 cultures for both, Figure 2B), but induced a depolarizing shift of isoguvacine currents from -165 
99+2 mV in control (21 neurons) to -85+2 in leptin-treated (13 neurons) cultures (6 cultures 166 
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for both, P=0.001, ANOVA followed by a Tukey’s post hoc test, Figure 2A,B). The leptin-167 
induced shift was abolished in neurons transfected with validated specific sh-RNAs (Dhar et 168 
al., 2014) to silence the expression of the LepRb (Figure 2B). In neurons transfected with a 169 
scramble shRNA, leptin was still able to depolarize EGABA (Figure 2B). Treatment with the 170 
selective KCC2 blocker VUO463271 (10µM) shifted EGABA towards more depolarized values 171 
and occluded the effect of leptin (Fig. 2 B). Leptin also decreased the rate of Cl
-
 extrusion by 172 
KCC2 in cultured neurons preloaded with Cl
-
, an effect mimicked by VUO463271 (Figure 173 
2C,D). The half-recovery time was 194+17 sec, 563+143 sec and 625+176 sec in respectively 174 
control (n=7 neurons), leptin-treated (6 neurons, P=0.018 when compared to control, two-175 
tailed unpaired Student’s t-test) and VUO463271-treated (n=4 neurons, P=0.79 when 176 
compared to leptin-treated, two-tailed unpaired Student’s t-test, Supplementary File 1) 177 
cultures. These data therefore show that leptin acts on hippocampal leptin receptor to down 178 
regulate KCC2 activity shifting EGABA towards depolarizing values in hippocampal neuronal 179 
cultures. 180 
  181 
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 182 
Figure 2: Leptin down-regulates KCC2 activity in cultured hippocampal neurons. 183 
(A) I-V relationships for isoguvacine currents in vehicle (control) and leptin-treated (100nM, 24h) hippocampal 184 
(15 DIV) cultures. Gramicidin perforated patch clamp recordings. Insets depict the isoguvacine currents. Scale 185 
bar, 500 ms, 100 pA. (B) Box plots of EGABA in the indicated conditions. *P<0.05, **P<0.01, ANOVA followed 186 
by a Tukey’s post hoc test. (C) Examples of isoguvacine currents (arrow heads) recorded at -80 and -40 mV 187 
before (t=-60 sec) and after (t=+20 and +420 sec) neuronal chloride loading in control neuronal culture (15 188 
DIV). Gramicidin perforated patch clamp recordings. Scale bar, 100 pA, 40 mV, 1s. (D) Summary plots of 189 
normalized EGABA recovery after neuronal chloride loading in the indicated conditions. Mean+SEM. In B and D, 190 
the number of cells recorded and number of cultures used are indicated in parenthesis. 191 
 192 
  193 
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We next asked whether leptin treatment altered KCC2 and NKCC1 expression. 194 
Western blotting revealed that the expression of the two chloride co-transporters was 195 
decreased in leptin-treated cultures (-85+0.8 and -66+0.6 % respectively, 5 cultures for both, 196 
P=2.01E-6 and 0.0008 respectively, two-tailed unpaired Student’s t-test, Figure 3D).  197 
However, the ratio of the KCC2/NKCC1 protein was reduced following leptin treatment 198 
(from 1.05+0.19 to 0.49+0.07, P=0.02, two-tailed unpaired Student’s t-test, Figure 3D).  199 
Immuno-labeling confirmed that KCC2 protein was decreased in leptin-treated cultures 200 
(Figure 1 – figure supplement 2). 201 
The total amount of KCC2 protein is not an accurate indicator of its activity since, to 202 
extrude Cl
-
,
 
KCC2 has to localize at the plasma membrane (Medina et al., 2014). We therefore 203 
assessed the abundance of KCC2 expressed in different cell compartments of control and 204 
leptin-treated cultured hippocampal neurons, using a KCC2 construct tagged in an external 205 
loop with a fluorescent protein (KCC2-pHext) (Friedel et al., 2015). Combined with a 206 
multistep immuno-labeling protocol, this construct allows to visualize the total amount of 207 
KCC2-pHext expressed by neurons (Ft), the amount of KCC2-pHext present at the cell surface 208 
(Fm) and the amount of KCC2-pHext internalized (Fi) (Figure 3A). Ft was similar in control 209 
and leptin-treated cultured neurons (1.1+0.13 vs 1.3+0.18 a.u., 16 and 19 neurons 210 
respectively, 3 cultures, P=0.89, ANOVA followed by a Tukey’s post hoc test, not shown). 211 
However, Fm was lower (1+0.16 vs 0.44+0.09 a.u., P=0.0028, ANOVA followed by a 212 
Tukey’s post hoc test) and Fi was higher (0.9+0.18 vs 1.7+0.15 a.u., P=0.04, ANOVA 213 
followed by a Tukey’s post hoc test) in leptin-treated cultures compared to control (Figure 214 
3A,B). Both effects were abolished when the expression of LepRb was silenced with two 215 
different specific sh-RNAs (Dhar et al., 2014) (Figure 3B). One batch of cultures was 216 
routinely transfected with KCC2 construct tagged in the intracellular N-terminus with a 217 
fluorescent protein as control experiment for cell membrane integrity during live-cell 218 
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immuno-labelling, (KCC2-pHint, Figure 3A). The multistep immuno-labeling protocol didn’t 219 
detect membrane expressed or internalized KCC2-pHint (Figure 3B). Altogether these data 220 
show that leptin reduces the expression of KCC2 and its plasma membrane stability in 221 
cultured hippocampal neurons.  222 
The membrane expression and transport activity of KCC2 strongly depend on the 223 
phosphorylated state of its intracellular C-terminus domain (Medina et al., 2014). 224 
Phosphorylation on the threonine 906 and 1007 residues (T906, T1007) inhibits KCC2 225 
activity and enhances KCC2 endocytosis, while phosphorylation of the serine 940 residue 226 
(S940) enhances KCC2 activity (Medina et al., 2014). We therefore assessed the 227 
phosphorylated state of KCC2 following leptin treatment in neuronal cultures. We found that 228 
the total amount of phospho-T906 KCC2 (pKCC2 T906), phospho-T1007 KCC2 229 
(pKCC21007) and phospho-S940 KCC2 (pKCC2S940) protein were decreased in leptin-230 
treated neuronal cultures (Figure 3C). However the ratio of pKCC2 T906 to total KCC2 231 
protein (pKCC2T906/KCC2) and pKCC2 T1007 to total KCC2 protein 232 
(pKCC2T1007/KCC2) were increased hence showing that the relative expression of these 233 
phosphorylated forms of KCC2 were increased by leptin treatment: the pKCC2T906/KCC2 234 
ratio increased from 1.1+0.1 to 2.2+0.08, and the pKCC2T1007/KCC2 ratio increased from 235 
1.4+0.2 to 2.9+0.3 (P=0.0003 and P=0.004 respectively, two-tailed unpaired Student’s t-test, 236 
5 independent neuronal cultures, Figure 3C,E). The relative expression of phospho-S940, 237 
calculated as the ratio of pKCC2 S940 to total KKC2 protein (pKCC2S940/KCC2) was 238 
however not modified (the ratio of pKCC2S940/KCC2 was 0.77+0.02 in control and 239 
0.083+0.03 in leptin-treated cultures, P=0.26, two-tailed unpaired Student’s t-test, 5 240 
independent neuronal cultures, Figure 3C,E). These results show that leptin treatment alters 241 
the phosphorylated state of KCC2 in hippocampal neuronal cultures.  242 
 243 
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WNK1 activity is required for KCC2 T906 and T1007 phosphorylation (Inoue et al., 244 
2012; Friedel et al., 2015). To test whether WNK1 is involved in the leptin-induced regulation 245 
of chloride homeostasis we expressed previously validated specific sh-RNA (Friedel et al., 246 
2015) to silence WNK1 expression (sh-WNK) or constitutively active WNK1 mutant (WNK-247 
CA) in hippocampal neuronal cultures and measured EGABA from gramicidin-perforated 248 
patch-clamp recordings after 24h of vehicle or leptin (100 nM) treatment (Figure 3F). In 249 
scramble expressing neurons, leptin treatment led to a depolarizing shift of EGABA from -93+2 250 
to -80+3 mV, n=8 and 20 neurons respectively, P=0.001, one way ANOVA followed by a 251 
Tukey’s post hoc test, Figure 3F). Genetic silencing of WNK1 prevented the depolarizing 252 
shift of EGABA induced by leptin-treatment (P=0.89 compared to control sh-WNK expressing 253 
neurons, one way ANOVA followed by a Tukey’s post hoc test, Figure 3F). In contrast, 254 
expressing WNK1-CA produced a depolarizing shift of EGABA (EGABA=-75+3.5 mV, P=0.001, 255 
one way ANOVA followed by a Tukey’s post hoc test when compared to scramble expressing 256 
neurons) and occluded the leptin action (P=0.89, one way ANOVA followed by a Tukey’s 257 
post hoc test, Figure 3F). Altogether these data suggest that leptin modulates the activity of 258 
KCC2 via a WNK1-dependent pathway in cultured hippocampal neurons. 259 
 260 
  261 
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 262 
Figure 3: leptin reduces the plasma membrane expression of KCC2 and modulates its 263 
phosphorylation state in cultured hippocampal neurons. 264 
(A) Representative images illustrating total, membrane and internalized pools of KCC2 with external tag 265 
(KCC2-pHext) in vehicle and leptin-treated (100 mM, 24h) cultured hippocampal neurons expressing a scramble 266 
Sh-RNA (Sh-Sbl). Neurons expressing KCC2 with internal tag (KCC2-pHint) were proceeded in parallel 267 
experiments to ensure that immunocytochemistry on living neurons does not permeabilized the membrane. Scale 268 
bars 20μm and 1μm. (B) Box plots of normalized membrane (Fm) and internalized (Fi) fluorescence in vehicle 269 
and leptin-treated (+Lep) cultured neurons expressing the indicated constructs. *P<0.05, one way ANOVA 270 
followed by a Tukey’s post hoc test. (C) Western blots and quantifications (D and E) of KCC2, NKCC1, 271 
KCC2/NKCC1 ratio and the threonine 906, threonine 1007 and serine 940-phosphorylated forms of KCC2 in 272 
control and leptin (100nM, 24h)-treated hippocampal neuronal cultures (DIV15, five independent neuronal 273 
cultures). ***P<0.001, two-tailed unpaired Student’s t-test. (F) Box plots of EGABA in the indicated conditions. 274 
Gramicidin perforated patch clamp recordings were performed on hippocampal neuronal cultures at 15 DIV. 275 
**P<0.01, ***P<0.001, one way ANOVA followed by a Tukey’s post hoc test. In B and F, the number of cells 276 
recorded and number of cultures used are indicated in parenthesis. 277 
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Maternal obesity and neonatal hyperleptinemia delay the emergence of GABAergic 278 
inhibition. 279 
Maternal obesity causes excess of leptin in offspring (Valleau and Sullivan, 2014; 280 
Tessier et al., 2013). We therefore asked whether maternal obesity may affect the GABA 281 
developmental sequence in the offspring. Female mice were fed with normal (ND) or high fat 282 
(HFD) diet (Figure 4-figure supplement 1). After 6 weeks, females were mated and 283 
maintained under their respective diet during the gestation and lactation period. Pups of HFD-284 
induced obese dams (DIO-pups) showed higher levels of serum leptin compared to offspring 285 
of ND dams (ND-pups) (16+1 ng/ml (n=6) vs 32+4 ng/ml (n=4) in respectively P10-P15 ND-286 
pups and DIO-pups, P=0.0049, two-tailed unpaired Student’s t-test, not shown). We 287 
investigated the effect of bath applied isoguvacine on the firing of CA3 hippocampal slices. 288 
We found that the excitatory-to-inhibitory switch of isoguvacine actions was delayed by about 289 
one week in DIO-pups compared to ND-pups (Figure 4A,B). Thus, isoguvacine increased the 290 
neuronal firing in ND-pups at P5 and decreased it starting from P10. In HFD-pups, 291 
isoguvacine increased the firing frequency up to P13. To assess whether hyperleptinemia 292 
mimicked the effect of maternal obesity, wt pups were treated with sub-cutaneous injections 293 
of recombinant leptin (5mg/kg, twice a day) from P2 to P10. At P10-11, isoguvacine 294 
decreased the neuronal firing of CA3 pyramidal neurons in vehicle-treated mice but not in 295 
leptin-treated mice (Figure 4C,D).  296 
Further, western blot analysis revealed that the expression of KCC2 was decreased in 297 
DIO-pups compared to ND-pups (-51+12 %, P=0.03, two-tailed unpaired Student’s t-test, 298 
Figure 4E,F) and in leptin-treated mice compared to vehicle-treated mice (-65+7 %, P=0.03, 299 
two-tailed unpaired Student’s t-test, Figure 4 E,F). Thus, hyperleptinemia as maternal obesity 300 
delays the GABA developmental sequence and down regulates KCC2 expression in offspring. 301 
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 302 
Figure 4: Hyperleptinemia and maternal obesity delay the GABA developmental 303 
sequence and downregulate KCC2 expression. 304 
 (A) Cell attached recordings of CA3 pyramidal neurons on acute hippocampal slices obtained from pups of 305 
normal diet (ND) and diet-induced obese (DIO) dams at P10. (B) Developmental changes of isoguvacine action 306 
on spike frequency. Mean + SEM. (C) Cell attached recordings of CA3 pyramidal neurons on acute hippocampal 307 
slices obtained from vehicle-treated (sham) and leptin-treated mice at P10. (D) Box plots of isoguvacine action 308 
on spike activity. In B and D, number of cells recorded and number of mice used are indicated in parenthesis; 309 
#P<0.05 when compared to pre-isoguvacine values, two-tailed paired Student’s t-test and *P<0.05 and **P<0.01 310 
when compared to age matched ND-pups (B and C) or sham-pups (E), two-tailed unpaired Student’s t-test. (E) 311 
Representative immuno-blots for hippocampal panKCC2 and 3-tubulin in offspring of DIO and ND dams at 312 
P13 and in control (sham) and leptin-treated (Lep) mice at P10. The third lanes (-) illustrate background (empty 313 
wells). (F) Normalized panKCC2 immunoreactivity in ND (n=6 pups) and sham (n=3 pups), in offspring of DIO 314 
(n=5 pups) and in leptin-treated mice (n=5 pups). Mean + SEM. *P<0.05, two-tailed unpaired Student’s t-test. 315 
 316 
 317 
 318 
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DISCUSSION 319 
Our data demonstrate that leptin is a key factor in setting the direction of GABAA 320 
receptor-mediated signaling in the developing hippocampus. We show that leptin exposure of 321 
hippocampal cultures leads to a depolarizing shift of GABAA receptor mediated responses 322 
and down-regulates KCC2 expression and membrane stability. Furthermore, in the absence of 323 
leptin signaling, hippocampal neurons show an early expression of KCC2 and an advanced 324 
development of GABAergic inhibition in vivo. Conversely, excess leptin down regulates the 325 
expression of KCC2 and delays the emergence of GABAergic inhibition in vivo. Previous 326 
studies have reported that the GABA switch is delayed in mice lacking oxytocin (Tyzio et al., 327 
2006; Leonzino et al., 2016) or the thyroid hormones (Friauf et al., 2008; Sawano et al., 328 
2013). Thus, the functional maturation of GABAergic synapses depends on an optimal and 329 
timely balance level of hormones that accelerate (oxytocin, thyroid hormones) or retard 330 
(leptin) the GABA switch. 331 
 332 
We have shown that leptin regulates the activity of KCC2 at the transcriptional and 333 
post-translational levels in vivo. The downstream pathway linking the long-form leptin 334 
receptor b (LepRb) and the functional expression of KCC2 remains to be elucidated. 335 
However, our data suggest that early in development, leptin surge promotes the 336 
phosphorylation of the threonine 906 and 1007 (T906/T1007) residues of KCC2 and reduces 337 
its membrane expression and activity via a WNK1-dependent pathway. This pathway seems 338 
to be quite specific in mediating leptin action, as we did not detect any changes in the 339 
phosphorylation of Ser940, a residue phosphorylated/dephosphorylated under other 340 
circumstances via protein kinase C (Lee et al., 2011). As development progresses, when leptin 341 
levels return to low level, the WNK1-dependent inhibitory action of KCC2 activity is 342 
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removed allowing the depolarizing-to-hyperpolarizing transition of GABA actions in the 343 
developing rodent hippocampus. Our model is supported by several lines of evidence 344 
obtained in vitro. We have shown that genetic silencing or activation of WNK1 respectively 345 
prevents or occludes the effect of leptin on EGABA. Moreover, we have shown that leptin 346 
treatment does not affect EGABA in immature cultured neurons, at a developmental stage when 347 
the activity of KCC2 is low and the activity of the WNK-pathway is high (Friedel et al., 348 
2015).  Finally, we have shown that leptin enhances the phosphorylation of the T906/T1007 349 
residues of KCC2, promotes the endocytosis of KCC2 and decreases its membrane 350 
expression. Of note, WNK1-regulated de-phosphorylation of the T906/1007 residues of 351 
KCC2 contributes to the depolarizing-to-hyperpolarizing GABA sequence in the developing 352 
hippocampus (Inoue et al., 2012; Friedel et al., 2015). Alanine substitutions of the 353 
T906/T1007 residues within the C-terminus of KCC2, mimicking a dephosphorylated state of 354 
KCC2, yield to hyperpolarized reversal potentials of GABA in neuronal cultures, ranging 355 
between -90 to -100 mV (Titz et al., 2015), i.e. the same order of magnitude to the values 356 
observed in db/db neurons (Figure 1D). Thus, the lack of leptin signaling in db/db and ob/ob 357 
mice may prevent the developmental WNK1-regulated changes in T906/T1007 KCC2 358 
phosphorylation in vivo, thereby leading to an advanced emergence of GABA inhibition in the 359 
newborn rodent hippocampus. 360 
Rodent studies show that the ability of GABA to depolarize immature neurons plays 361 
an essential role in the assembly of functional networks during development (Ben-Ari et al., 362 
2012). Advanced GABAergic inhibition or premature expression of KCC2 lead to long 363 
lasting disturbance of glutamatergic and GABAergic inputs and behavioral abnormalities in 364 
adult mice (Wang and Kriegstein, 2008; Wang and Kriegstein, 2011; Deidda et al., 2015; 365 
Cancedda et al., 2007; Chudotvorova et al., 2005). Accordingly, hippocampal network 366 
formation and function are impaired in db/db mice (Guimond et al., 2014; Harvey, 2013; Van 367 
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Doorn et al., 2017). However, it is impossible to ascertain whether the early emergence of 368 
GABA inhibition is a direct cause of these abnormal behaviors since leptin also directly 369 
impacts many aspect of brain development (Guimond et al., 2014; Harvey, 2013; Bouret, 370 
2010) that may contribute to behavioral deficit in db/db mice.   371 
Although translating animal research to the human situation is difficult, the GABA 372 
developmental sequence and leptin surge occurring during the second postnatal week of life 373 
in mouse are shifted towards fetal stage in humans (Chen and Kriegstein, 2015; Sedmak et al., 374 
2016; Valleau and Sullivan, 2014). This seems in contradiction with the classical satiety 375 
function of leptin since during pregnancy nutriments availability should be enhanced to 376 
optimize fetal growth. However, animal studies suggest the existence of a pregnancy-induced 377 
leptin resistance of the mother’s brain and accumulating evidence indicate that leptin has 378 
numerous actions before birth on fetal growth (Briffa et al., 2015). Importantly, leptin 379 
deficiency in this period is associated with long term consequences such as cognitive defects, 380 
anxiety, and depression. Conversely, leptin replacement alleviates these symptoms, 381 
suggesting that leptin is a crucial factor in brain development and mental health (Wang et al., 382 
2016; Rivera et al., 2015). Thus, during pregnancy, leptin may act beyond its classical satiety 383 
role and operates as an important developmental signal of fetal brain development. 384 
Our data also indicate that excess leptin delays the GABA switch in offspring. 385 
Defective chloride homeostasis primes the brain to malfunction contributing to autistic-like 386 
phenotypes associated with neurological disorders (Tyzio et al., 2014; He et al., 2014; Deidda 387 
et al., 2015; Banerjee et al., 2016). Moreover, it is noticeable that bumetanide treatment, that 388 
restores low [Cl
-
]I and alleviates autistic-like symptoms in rodents (Tyzio et al., 2014; 389 
Banerjee et al., 2016), also improves the symptoms of ASD in humans (Lemonnier et al., 390 
2017). The ability of leptin to regulate chloride homeostasis may therefore have important 391 
implications in health, but also in the emergence of neurological disorders associated with 392 
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abnormal GABAergic transmission. ASD are often associated with higher levels of leptin in 393 
circulation (Rodrigues et al., 2014; Rodrigues et al., 2014; Lisik et al., 2016). Interestingly, 394 
maternal obesity which is associated with hyperleptinemia (Valleau and Sullivan, 2014; 395 
Tessier et al., 2013) increases the risk of developing mental and behavioral disorders in 396 
offspring (Wang et al., 2016; Rivera et al., 2015), such as attention deficit hyperactivity 397 
disorder (ADHD), ASD, anxiety, depression, schizophrenia and impairments in cognition, 398 
which among many modifications, are associated with altered GABAergic transmission . 399 
Animal models of maternal high-fat diet induced obesity also document persistent changes in 400 
offspring behavior such as hyperactivity, impairments in social behavior, depressive-like 401 
behaviors and diminished cognition (Rivera et al., 2015).  402 
 403 
In conclusion, optimal levels of leptin are critical during development for a timely 404 
emergence of GABAergic inhibition. Epidemiological studies showed that the prevalence of 405 
obesity among childbearing age women has steadily increased during the past 20 years in 406 
most developed nations (An and Xiang, 2016; Flegal et al., 2012). Leptin thus lies at the 407 
crossroad between neurological, metabolic and nutritional disorders that may arise from 408 
societal changes in lifestyle, stress level and eating behaviors. 409 
  410 
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MATERIAL and METHODS 411 
Key Resources 
Table 
    
Reagent type 
(species) or resource 
Designation Source or reference Identifiers 
Additional 
information 
genetic reagent 
( M. musculus) 
B6.Cg-Lepob/J The Jackson Laboratory 
RRID:IMSR_JAX:000
632 
  
genetic reagent  
( M. musculus) 
B6.BKS-Leprdb The Jackson Laboratory 
RRID:IMSR_JAX:000
697 
  
Transfected DNA 
construct 
shLepR 3426 
PMID:24877561,  DOI: 
10.1210/me.2013-1332 
  
Dr. G. Wayman 
(Washington State 
University) 
transfected DNA 
construct 
shLepR 3299 
PMID:24877561,  DOI: 
10.1210/me.2013-1332 
  
Dr. G. Wayman 
(Washington State 
University) 
transfected DNA 
construct 
WNK shRNA 
PMID: 26126716, DOI: 
10.1126/scisignal.aaa0354  
    
transfected DNA 
construct 
WNK-CA 
PMID: 26126716, DOI: 
10.1126/scisignal.aaa0354 
  
transfected DNA 
construct 
KCC2-pHluorin 
PMID: 24928908, DOI: 
10.15252/embr.201438840 
    
antibody 
Mouse anti-3 
tubulin 
Sigma-Aldrich 
RRID:AB_477590, 
Cat# T8660  
WB (1:10 000) 
antibody Rabbit anti-KCC2 US Biological 
RRID:AB_2188802, 
Cat# K0120-07  
WB (1:2000) 
antibody 
Donkey anti-chiken 
Alexa488 
Fluoprobes 
RRID: AB_2686906, 
Cat# FP-SA5110 
IHC (1:1000) 
antibody Chicken anti-MAP2 Abcam 
RRID:AB_2138153, 
Cat# ab5392  
IHC (1:2000) 
antibody 
Donkey Anti-rabbit 
Cy3 
Chemicon 
RRID:AB_92588, Cat# 
AP182C  
IHC (1:1000) 
antibody mouse Anti-GFP Novus Biologicals  
RRID:AB_531011, 
Cat# NB 600-597 
  
antibody NKCC1 total 
the Division of Signal 
Transduction Therapy Unit 
(DSTT) at the University of 
Dundee 
dundee (S022D) WB (1mg/ml) 
antibody pan KCC2   
 
Dr. C. Rivera 
(University of 
Helsinki) 
antibody KCC2 Ser940  Novus Biologicals Cat# NBP2-29513 WB (1mg/ml) 
antibody 
KCC2a 
phosphoT1007  
the Division of Signal 
Transduction Therapy Unit 
(DSTT) at the University of 
Dundee 
dundee (S959C) WB (1mg/ml) 
antibody 
KCC2a 
phosphoT906  
the Division of Signal 
Transduction Therapy Unit 
(DSTT) at the University of 
Dundee 
dundee (S959C) WB (1mg/ml) 
Oligonucleotides Slc12a2 (NKCC1) Qiagen QT00197785   
Oligonucleotides Slc 12a5 (KCC2) Qiagen  QT00145327   
Oligonucleotides GAPDH Qiagen  QT001199633   
peptide, recombinant 
protein 
Recombinant 
murine leptin 
Tocris, Cat# TO-2985/1   
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commercial assay or 
kit 
Mouse leptin 
ELISA kit BioVendor R & DR 
Cat#  RD291001200   
chemical compound, 
drug 
1,2,3,4-Tetrahydro-
6-nitro-2,3-dioxo-
benzo[f]quinoxaline
-7-sulfonamide 
(NBQX) 
NIMH Chemical Synthesis 
and Drug Supply Program, 
https://nimh-repository.rti.org/ 
    
chemical compound, 
drug 
D-2-amino-5-
phosphovaleric acid 
(D-APV) 
NIMH Chemical Synthesis 
and Drug Supply Program, 
https://nimh-repository.rti.org/ 
    
chemical compound, 
drug 
1,2,3,4-Tetrahydro-
6-nitro-2,3-dioxo-
benzo[f]quinoxaline
-7-sulfonamide 
(NBQX) 
NIMH Chemical Synthesis 
and Drug Supply Program, 
https://nimh-repository.rti.org/ 
    
chemical compound, 
drug 
Isoguvacine Tocris Cat# 0235   
chemical compound, 
drug 
VU0463271 Tocris Cat# 4719   
chemical compound, 
drug 
Bumetanide Sigma Cat# B3023   
Software and 
Algorithms 
National Institutes 
of Health 
  RRID:SCR_003070   
Software and 
Algorithms 
Synaptosoft, 
http://www.synapto
soft.com/MiniAnal
ysis/DownloadDem
o.html 
      
 412 
Animals 413 
All animal procedures were carried out in accordance with the European Union Directive of 414 
22 September (2010/63/EU). Experiments were performed on both male and female postnatal 415 
day (P) 4 and 5 Wistar rats and P1 to P20 C57BL/6 transgenic mice lacking leptin (ob/ob) or 416 
leptin receptor (db/db) expression (purchased from Charles River Laboratory, Italy). Control 417 
experiments were performed on wild type (wt) littermates. Animals were housed in a 418 
temperature-controlled environment with a 12 light/dark cycle and free access to food and 419 
water. Mice were genotyped following the Jackson Laboratory genotyping protocol (strains 420 
B6.Cg-Lep
ob
/J, ID 000632 and B6.BKS-Lepr
db
, ID 000697). For each experiment, tissues 421 
from littermate wt and KO mice were prepared and the persons assessing and quantifying the 422 
outcomes were blinded to the genotype of the mice.  423 
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To assess the effect of maternal obesity, 8 weeks old C57BL/6 female were fed with a high-424 
fat diet (HFD, 60% kcal from fat, D12492, Research Diet) or a normal diet (ND, 10% kcal 425 
from fat, D12450B, Research Diet) during 6 weeks at the end of which they were weighed 426 
and mated. All female were maintained during gestation and lactation on the same diet 427 
received before. 428 
 429 
Leptin injection 430 
Recombinant murine leptin was reconstituted in PBS buffer pH 7.4, and injected (5mg/kg) 431 
sub-cutaneous in wt and ob/ob pups twice a day at 9-10h a.m and 5-6h p.m. Control received 432 
same volume injections of vehicle, pH 7.4. 433 
 434 
Leptin immunoassay 435 
The plasma samples were centrifuged (10.000rpm, 10 min, 4°C) immediately after collection 436 
of arteriovenous blood samples obtained from 0 to 20 days old wt and db/db mice at 10-11h 437 
a.m. Plasma samples from leptin-treated mice (ob/ob and wt mice) were obtained 30 min to 438 
1h after the last sub-cutaneous injection. Plasma was collected and stored at -80°C. 439 
Quantification of endogenous leptin was performed with Mouse Leptin ELISA Kit 440 
(BioVendor R&D) in the concentrated solutions following the manufacturer’s protocol. The 441 
measured concentration of samples was calculated from the standard curve and expressed as 442 
ng/ml.  443 
 444 
Hippocampal slice preparation and electrophysiological recordings 445 
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Brains were removed and immersed into ice-cold (2-4°C) artificial cerebrospinal fluid 446 
(ACSF) with the following composition (in mM):  126 NaCl, 3.5 KCl, 2 CaCl2, 1.3 MgCl2, 447 
1.2 NaH2PO4, 25 NaHCO3 and 11 glucose, pH 7.4 equilibrated with 95% O2 and 5% CO2. 448 
Hippocampal slices (600 µm thick) were cut with a McIlwain tissue chopper (Campden 449 
Instruments Ltd.) and kept in ACSF at room temperature (25°C) for at least one hour before 450 
recording. Slices were then transferred to a submerged recording chamber perfused with 451 
oxygenated (95% O2 and 5% CO2) ACSF (3 ml/min) at 34°C. 452 
EGABA measurement: Perforated patch-clamp recordings were made from CA3 pyramidal 453 
neurons using an axopatch 200B (Axon Instrument) or Multiclamp 700B (Molecular devices) 454 
amplifier. Glass recording electrodes had resistances of 4-7 M when filled with KCl solution 455 
containing 150mM KCl and 10 mM HEPES, pH adjusted to 7.2 with Tris-OH. The pipettes 456 
were tip filled with a gramicidin-free KCl solution and then backfilled with the same solution 457 
containing gramicidin A (50µg/ml, diluted from a 50mg/ml stock solution in DMSO). After 458 
the access resistance had dropped (40 to 80 M) and stabilized (15-30 min), a current-voltage 459 
relationship was constructed by measuring the peak amplitude of averaged evoked 460 
GABAergic synaptic current (3 single sweeps) at different holding potentials in 10 mV 461 
increment recorded in the presence of glutamatergic receptor antagonists (NBQX 5µM and D-462 
APV 40µM). Measurements were not corrected for the liquid junction potentials. A linear 463 
regression was used to calculate the best-fit line of the voltage dependence of the synaptic 464 
currents. Spontaneous rupture into whole-cell was evidenced by large inward synaptic 465 
currents due to ECl of 0mV.  466 
Isoguvacine effect on neuronal firing: Loose cell attached patch clamp recordings were 467 
performed from CA3 pyramidal neurons using an axopatch 200B (Axon Instrument) with 468 
glass electrodes (4-7 M) filled with KCl solution containing 150mM KCl and 10 mM 469 
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HEPES, pH adjusted to 7.2 with Tris-OH. After a baseline period of at least 10 min in the 470 
presence of NBQX (5µM) and D-APV (40µM), isoguvacine (10µM) was bath applied for 2 471 
min. The effect of isoguvacine was quantified as the mean frequency of action potential 472 
following application of isoguvacine (4-8 min) versus baseline frequency (-10-0 min). 473 
Synaptic activity were recorded with Axoscope software version 8.1 (Axon
 
Instruments) and 474 
analyzed offline with
 
Mini Analysis Program version 6.0 (Synaptosoft). 475 
 476 
Western Blotting 477 
Whole hippocampi were obtained from P5-6 mice as described above. Hippocampi were 478 
homogenized in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.1% SDS, 50 mM Tris HCl, 479 
pH 8, containing proteinases and phosphatases inhibitors (Complete Mini, Roche). Lysates 480 
were centrifuged (1.000g for 10 min at 4°C) and the supernatant was heated at 90°C for 5 min 481 
with Laemmli loading buffer. Loading was 20 µg of proteins as determined using a BCA 482 
protein Assay Kit (Thermo Scientific). Proteins were separated in 7–15% SDS-PAGE and 483 
electrophoretically transferred to nitrocellulose membranes. Membranes were blocked with 484 
5% bovine serum albumin (BSA) in TBS 0.1% Tween 20 (TBST) for 2 h at RT, then 485 
incubated with primary antibodies diluted in TBST containing 3% BSA overnight at 4°C or 2 486 
h at RT. Blots were probed with antibody against KCC2 (1:2000; rabbit, US Biological) and 487 
tubulin (1:10.000; ß-tubulin, mouse, Sigma). After washing with TBST, membranes were 488 
incubated with HRP-conjugated secondary antibodies diluted in TBST containing 3% BSA 489 
for 60 min, washed with TBST, and then developed using the G:BOX gel imaging system 490 
(Syngene). Expression levels were estimated by ImageJ software. 491 
 492 
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Real-time qRT-PCR 493 
Whole hippocampi were obtained from P6 mice as described above. RNA was isolated and 494 
quantified by reading the absorbance at 260 nm (NanoPhotometer, IMPLEN) using Mini 495 
RNeasy kit (Qiagen), then converted to cDNA using 1 µg RNA and a QuantiTect Reverse 496 
Transcription kit (Qiagen) according to manufacturer’s instructions. PCR was carried out with 497 
the LightCycler 480 SYBR Green I Master (Roche Applied Science) with 1 µL cDNA using 498 
the following oligonucleotides (QuantiTect Primer Assays, Qiagen): NKCC1 (Slc12a2; 499 
QT00197785), KCC2 (Slc12a5; QT00145327) and glyceraldehyde-3-phosphate 500 
dehydrogenase (GAPDH, QT001199633). Quantitative RT-PCR was performed with a Roche 501 
LC480 Light Cycler (Roche Applied Science) following the manufacturer’s instructions. 502 
Relative mRNA values were calculated using the LC480 software and GAPDH as the 503 
housekeeping gene. PCR was performed in replicate of 3. 504 
 505 
Immuno-staining 506 
Brains were removed from P6 mice and fixed overnight at 4°C in 4% paraformaldehyde 507 
(PFA). Brains were rinsed in phosphate buffer saline (PBS, 0.1M) and coronal sections (70 508 
µM thick) were obtained using a vibratome (Microm HVM 650V). Section were incubated 509 
first for 1h in PBS with 1% bovine serum albumin (BSA) and 0.3% Triton X-100, then 510 
overnight at 4°C with a rabbit anti-panKCC2 primary antibody (1:4000; non commercial, gift 511 
from Dr. C. Rivera). Sections were rinsed in PBS and incubated for 2h with an Alexa Fluor 512 
488 donkey anti-rabbit secondary antibody (1:1000, FluoProbes). Sections were 513 
counterstained for Nissl bodies, rinsed in PBS and mounted on microscope slides using 514 
Vectashield mounting medium (Vector). Immuno-reactivity was visualized using a laser 515 
scanning confocal microscope (LSM 510 Meta, Zeiss) with a 20X air objective and a 63X oil 516 
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immersion objective. Optical sections were digitized (1024 x 1024 pixels) and processed 517 
using ImageJ software (National Institutes of Health, http://rsb.info.nih.gov/ij/). Analysis of 518 
the intensity of the distribution of KCC2 fluorescence was performed at high magnification 519 
(×63 objective) using the Image J program. The same straight line length (3µm) was applied 520 
from the nucleus to the external cell compartment. The Plot profile values were analyzed and 521 
we normalized the fluorescence intensity to the highest intensity of the control condition. The 522 
intensity of KCC2 staining in neuronal cells was expressed as the mean ratio of 523 
KCC2/Neurotracer staining intensity. 524 
 525 
Primary cultures, transfection of rat hippocampal neurons, electrophysiological 526 
recordings, live cell immuno-labelling, Immuno-staining and Immunoprecipitation with 527 
phosphorylation site–specific antibodies 528 
 529 
Hippocampi from 18-day-old rat embryos were dissected and dissociated using trypsin 530 
(0.05%) and plated at a density of 70,000 cells cm−2 in minimal essential medium (MEM) 531 
supplemented with 10% Nu-Serum (BD Biosciences), 0.45% glucose, 1 mM sodium 532 
pyruvate, 2 mM glutamine, and penicillin-streptomycin (10 IU ml−1) as previously described 533 
(23). On days 7, 10, and 13 of culture incubation (DIV, days in vitro), half of the medium was 534 
changed to MEM with 2% B27 supplement (Invitrogen). For electrophysiology neuronal 535 
cultures were plated on coverslips placed in 35-mm culture dishes. Twenty-four hours before 536 
plating, dishes with coverslips were coated with polyethylenimine (5 mg/ml).  537 
For the analysis of KCC2 immuno-staining, KCC2-GFP clusters and electrophysiological 538 
experiments, pyramidal neurons were selected based on their morphology (Benson et al., 539 
1994).  540 
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Gramicidin-perforated patch-clamp recordings were performed at 23-24°C as previously 541 
reported (Friedel et al., 2015) (details are in supporting information). Series resistance was 542 
monitored routinely at a Vh of −80 mV with 5-mV hyperpolarizing pulses, typically taking 10 543 
to 15 min for the series resistance to stabilize at 15 to 60 M). Data were low pass–filtered at 544 
2 kHz and acquired at 10 kHz. Isoguvacine (30 mM) was focally applied (50 to 150 ms, 545 
10,000 to 30,000 Pa) to the neuron soma and proximal dendrites through a micropipette 546 
connected to a Picospritzer (General Valve Corporation). Isoguvacine responses were 547 
recorded at voltages −120, −100, −80, and −60 mV. A linear regression was used to calculate 548 
the best-fit line of the voltage dependence of the synaptic currents. For analysis of Cl
-
 549 
extrusion kinetic all neurons were overloaded with identical amount of [Cl
-
]i resulting in 550 
EGABA=-40 mV (~30 mM of [Cl
-
]i). This was achieved by repetitive three-pulse applications 551 
of isoguvacine (100 ms pulses with interval 500 ms) at 0 mV followed by a single 552 
isoguvacine application (100 ms) at -40 mV until disappearance of the outwardly directed 553 
isoguvacine-induced current at -40 mV. This later corresponded to EGABA=-40 mV. 20 sec 554 
after the loading protocol, a pair of 100 ms isoguvacine pulses at -40 mV and -80 mV 555 
(interval 500 ms) was applied every 10 s to monitor the EGABA. For quantification of Cl
-
 556 
extrusion kinetic, EGABA at each time point was first normalized to the mean control, pre-557 
loading EGABA values. These normalized values were then normalized to the normalized 558 
EGABA obtained 20 sec after the loading protocol (-49+2 mV for control experiments, n=7 559 
neurons, 3 cultures). 560 
For transfection of cultures growing in 35-mm dishes, 300 ml of Opti-MEM was mixed with 561 
7 ml of Lipofectamine 2000 (Invitrogen), 1 ml of Magnetofection CombiMag (OZ 562 
Biosciences), and 1 to 1.5 mg of different pcDNAs premixed in desired proportions. The 563 
mixture was incubated for 20 min at room temperature and thereafter distributed dropwise 564 
above the neuronal culture. Culture dishes were placed on a magnetic plate (OZ Biosciences) 565 
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and incubated for 30 to 35 min at 37°C. Transfection was terminated by the substitution of 566 
90% of the incubation solution with fresh culture medium. The experiments were based on 567 
cotransfection into the same cell of two different pcDNAs encoding a fluorescent marker of 568 
transfection (eGFP, 0.3 µg), shRNAs (1.2 µg) against leptin receptor or WNK1, scrambled 569 
shRNAs or WNK1 construct. We used two shRNAs targeting different regions on the LepRb 570 
gene. The efficacy of these shRNAs has been tested in a previous study on human kidney 571 
cells and cultured hippocampal neurons (Dhar et al., 2014). The efficacy of the WNK1 572 
construct and shRNA has been tested in a previous study in PC-12 and N2a cell line and 573 
cultured hippocampal neurons (Friedel et al., 2015).  574 
For immunocytochemistry on living neurons, rabbit anti-GFP antibody were diluted in 575 
culture medium and applied to neurons for 2 hours at 37°C, 5% CO2. Neurons were then 576 
rinsed three times for 10 min at room temperature with Hepes-buffered saline solution 577 
containing 150 mM NaCl, 2.5 mM KCl, 2.0 mM MgCl2, 2.0 mM CaCl2, 20 mM Hepes, and 578 
10 mM D-glucose (pH 7.4), labeled with anti-rabbit Cy3-conjugated antibody (dissolved in 579 
the Hepes buffered saline) for 20 min at 13°C and fixed in Antigenfix (Diapath). To reveal 580 
intracellular pool of live-labelled proteins, cells were subsequently permeabilized with 0.3% 581 
Triton X-100, blocked by 5% goat serum and incubated during 1 h at room temperature (RT) 582 
with anti-rabbit Alexa 647-conjugated antibody. Then, for visualization of the entire pool of 583 
overexpressed KCC2-pHext cells were labeled overnight (4°C) with mouse anti-GFP antibody 584 
and for 1 hour at RT with anti-mouse Alexa 488-conjugated antibody. For control of the cell 585 
integrity during live-cell immunolabelling, one batch of cultures were routinely transfected 586 
with KCC2 construct harboring phluorine tag linked to the intracellular N-terminus of the 587 
transporter.  588 
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Images of labeled cells were acquired with an Olympus Fluorview-500 confocal microscope 589 
(oil-immersion objectives 40x, (NA1.0) or 60x (NA1.4); zoom 1-5). We randomly selected 590 
and focused on a transfected cell by only visualizing Alexa-488 fluorescence and then 591 
acquired Z-stack images of Alexa-488, CY3 and Alexa-647 fluorochromes emitted 592 
fluorescence using, respectively green (excitation 488 nm, emission 505-525 nm), red 593 
(excitation 543 nm emission 560-600 nm) and infra-red (excitation 633, emission >660 nm) 594 
channels of the microscope. Each Z-stack included 10 planes of 1 µm optical thickness and 595 
taken at 0.5 µm distance between planes. The cluster properties and fluorescence intensities of 596 
each cell were analyzed with Metamorph software. First, we used the logical “NOT” 597 
conversion of pairs of Alexa-647 and CY3 images to isolate in each focal plane the Alexa-647 598 
signal that was not overlapping with CY3 fluorescence restricted to plasma membrane. This 599 
gave rise to additional images reflecting the fluorescence of the internalized pool of labeled 600 
clusters, called thereafter “NOT-conversion”. Second, the arithmetic summation for each Z-601 
stack and channel was performed to collect the whole fluorescence of the different signals 602 
(Alexa-488 = total protein fluorescence; CY3 = plasma membrane restricted fluorescence; 603 
NOT-conversion = internalized restricted fluorescence; Alexa-647 = all surface labeled 604 
fluorescence). Third, a binary mask was created for each cell from Alexa-488 image to isolate 605 
the signal coming from the transfected neuron, and the fluorescence parameters (total 606 
fluorescence, single cluster fluorescence as well as density and brightness of clusters) were 607 
analyzed for each channel (Alexa-488, CY3, NOT-conversion and Alexa-647) in regions 608 
overlapping with the binary mask. The analysis parameters were the same for each 609 
experiment and all experiments were done blind. After analysis, data were normalized to the 610 
mean value of cells transfected with KCC2-pHext + scrambled shRNA. 611 
For immuno-staining, hippocampal cultures (75,000 cells/cm
2
, DIV 14) were fixed in 4% 612 
PFA-sucrose for 10 min. Coverslips were washed in PBS for 15 min and incubated in 0.2 M 613 
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glycine for 10 min. Blocking was done in 1% BSA/0.5% Triton X-100 in PBS for 30 min to 614 
permeabilize cells and reduce nonspecific binding. Cultures were washed and incubated with 615 
a rabbit anti-panKCC2 (1:4000; non commercial , gift from Dr. C. Rivera) coupled to chicken 616 
anti-MAP2 (1:2000, Microtubule-associated protein 2, Sigma) antibodies in PBS overnight at 617 
4°C. Primary antibodies were visualized after staining with the appropriate goat anti-rabbit 618 
and anti-donkey IgG conjugated to Cy3 (1:1000, chemicon) and Alexa488 (1:1000, 619 
FluoProbes), respectively in 1% BSA/PBS for 60 min. Cultures were washed and coverslips 620 
mounted using Vectashield (Vector). Sequential acquisition of immunoreactivity was 621 
visualized using laser scanning confocal microscope (Zeiss LSM 510 Meta) with a x63 oil-622 
immersion objective. In each image, laser light levels and detector gain and offset were 623 
adjusted to avoid any saturated levels. Confocal micrographs are digital composites of a Z-624 
series scan of 4 – 6 optical sections through a depth of 4 – 5 µm. 625 
 626 
For the immunoprecipitation with phosphorylation site–specific antibodies, KCCs 627 
phosphorylated at the KCC2 Thr906 and Thr1007 equivalent residue were immuno-628 
precipitated from clarified control and leptin (100nM, 24h) treated-hippocampal culture 629 
lysates (centrifuged at 16,000g at 4°C for 20 min) using phosphorylation site–specific 630 
antibody coupled to protein G–Sepharose. The phosphorylation site–specific antibody was 631 
coupled with protein G–Sepharose at a ratio of 1 mg of antibody per 1 ml of beads in the 632 
presence of lysate (20 mg/ml) to which the corresponding nonphosphorylated peptide had 633 
been added. Two milligrams of clarified cell lysate was incubated with 15 mg of antibody 634 
conjugated to 15 ml of protein G–Sepharose for 2 hours at 4°C with gentle agitation. Beads 635 
were washed three times with 1 ml of lysis buffer containing 0.15 M NaCl and twice with 1 636 
ml of buffer A. Bound proteins were eluted with 1× LDS sample buffer.  637 
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Cell lysates (15 mg) in SDS sample buffer were subjected to electrophoresis on 638 
polyacrylamide gels and transferred onto nitrocellulose membranes. The membranes were 639 
incubated for 30 min with TTBS containing 5% (w/v) skim milk. The membranes were then 640 
immunoblotted in 5% (w/v) skim milk in TTBS with the indicated primary antibodies 641 
overnight at 4°C. Antibodies prepared in sheep were used at a concentration of 1 to 2 mg/ml. 642 
The incubation with phosphorylation site–specific sheep antibodies was performed with the 643 
addition of the non-phosphorylated peptide antigen (10 mg/ml) used to raise the antibody. The 644 
blots were then washed six times with TTBS and incubated for 1 hour at room temperature 645 
with secondary HRP-conjugated antibodies diluted 5000-fold in 5% (w/v) skim milk in 646 
TTBS. After repeating the washing steps, the signal was detected with the enhanced 647 
chemiluminescence reagent. Imumunoblots were developed by ChemiDoc™ Imaging 648 
Systems (Bio-Rad). Figures were generated using Photoshop and Illustrator (Adobe). The 649 
relative intensities of immunoblot bands were determined by densitometry with ImageJ 650 
software. 651 
Antibodies used for western blots were raised in sheep and affinity-purified on the appropriate 652 
antigen by the Division of Signal Transduction Therapy Unit (DSTT) at the University of 653 
Dundee; other antibodies were purchased. NKCC1 total (S022D, first bleed, raised against 654 
residues 1-288 of human NKCC1); KCC2a phosphoT906 (S959C, first bleed; raised against 655 
residues 975–989 of human KCC3a phosphorylated at T991, SAYTYER(T)LMMEQRSRR); 656 
KCC2a phosphoT1007 (S961C, first bleed; raised against residues 1032–1046 or 1041–1055 657 
of human KCC3a phosphorylated at T1048). KCC2 Ser940 antibody (NBP2-29513, Novus 658 
Biologicals). KCC2 total antibody (S700C, first bleed; raised against residues 1–119 of 659 
human KCC2A); The anti-β-Tubulin III (neuronal) antibody (T8578) was purchased from 660 
Sigma-Aldrich. Secondary antibodies coupled to horseradish peroxidase used for 661 
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immunoblotting were obtained from Pierce. IgG used in control immunoprecipitation 662 
experiments was affinity-purified from pre-immune serum using Protein G-Sepharose. 663 
 664 
Reagents 665 
The following reagents were purchased from the indicated sources: 1,2,3,4-Tetrahydro-6-666 
nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide (NBQX) and D-2-amino-5-667 
phosphovaleric acid (D-APV) from the Molecular, Cellular, and Genomic Neuroscience 668 
Research Branch (MCGNRB) of the National Institute of Mental Health (NIMH, Bethesda, 669 
MD, USA). Leptin, Isoguvacine and VU0463271 from Tocris Cookson (Bristol, UK). 670 
Bumetanide from Sigma (St Louis, MO, USA). 671 
 672 
Statistics 673 
No statistical methods were used to predetermine sample sizes, but our sample sizes 674 
correspond to those reported in previous publications (Tyzio et al., 2006; Dhar et al 2014; 675 
Friedel et al., 2015). To ensure the consistency and reproducibility of our results, we 676 
conducted repeated trials in different cell cultures, acute brain slice and hippocampi prepared 677 
from at least three different animals for each experimental condition.  In this study, the 678 
persons performing experiments and analyzing the data were blinded to the genotype of the 679 
mice. These include electrophysiological recordings on acute slices, western blot, and PCR. 680 
The one way ANOVA followed by a Tukey’s post hoc test was used for multiple comparisons 681 
between experimental conditions. A two-tailed unpaired Student’s t-test was used to analyze 682 
difference between two individual groups. A two-tailed paired Student’s t-test was used to 683 
analyze differences within one group across conditions, i.e. frequency of action potential 684 
before and after isoguvacine. All data are expressed as Mean + standard error to the mean 685 
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(S.E.M.). Data are judged significantly different when P<0.05. Statistical information is 686 
provided in the figures, figure legends and text.  687 
  688 
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Supplementary figures legends 689 
Figure 1-figure supplement 1: Leptin controls GABA signaling in the mice hippocampus 690 
in vivo. 691 
(A) Plasma leptin levels in P8 wt, ob/ob and leptin-treated ob/ob mice (ob + lep, 5mg/kg twice a day sub-692 
cutaneous from P3 to P8, n=4, blood samples were collected 30 min after the last injection). (B) Box plot of 693 
isoguvacine action on spike frequency in wt mice, ob/ and leptin-treated ob/ob mice at P8. (C,D) Box plots of 694 
EGABA and Em at zero current in 4 wt mice, ob/ob and leptin-treated ob/ob CA3 pyramidal neurons. The cells 695 
recorded and number of animal used are indicated in parenthesis *P<0.05, **P<0.01, one way ANOVA followed 696 
by a Tukey’s post hoc test. 697 
 698 
Figure 1-figure supplement 2: KCC2 expression in db/db hippocampal neurons in vivo 699 
and leptin-treated hippocampal neuronal cultures in vitro.  700 
(A) Confocal images showing KCC2 immuno-labeling in the CA3 pyramidal layer of wt and db/db hippocampi 701 
at P6. (B) Summary plot of the normalized KCC2 fluorescence intensity ratio in P6 wt and db/db hippocampal 702 
CA3 pyramidal layer. Calibration bar 20µm. 3 wt and db/db littermate animals. mean +/- sem. ** p<0.01, two-703 
tailed unpaired Student’s t-test. (C) Examples of KCC2 and MAP2 immunostaining in control and leptin-treated 704 
(100 nM, 24h) cultured hippocampal neurons (15 DIV). Scale bar 20µM. (C) Summary plots of the normalized 705 
KCC2 fluorescence intensity in control (n=30) and leptin-treated (n=45) hippocampal neurons. Pooled data from 706 
3 different cultures. 707 
Figure 1-figure supplement 3: Raw blots for panel F (WT and db). 708 
 709 
Figure 4-figure supplement 1: High fat diet induced obesity. 710 
(A) Experimental overview. (B) Body weight curves of adult (8 weeks old) female mice fed with normal diet 711 
(10% kcal from fat, ND white symbols, n=4) or a high fat diet (60% kcal from fat, HFD, n=12). (C) Average 712 
body weight increase after 6 weeks of food supply. *P<0.05, ** P<0.01, two-tailed unpaired Student’s t-test. 713 
Figure 4-figure supplement 2: Raw blots for panel E (ND and DIO). 714 
Figure 4-figure supplement 3: Raw blots for panel E (Lep and sham). 715 
  716 
 
36 
 
 717 
 718 
 719 
 720 
Acknowledgments 721 
 722 
We thank Dr. Y. Ben-Ari for helpful support and suggestions during this study; Drs. R. 723 
Cossart and N. Kourdougli for reading of the manuscript and Drs. E. Cherubini, C. Rivera and 724 
E. Sernagor for helpful critical comments on the study. This work was supported by the 725 
Ministère de la Recherche et de l’Enseignement Supérieur, Neurochlore (CD) and the 726 
National Institutes of Health (Grant MH086032, GW). 727 
 728 
 729 
 730 
  731 
 
37 
 
 732 
Reference List 733 
 1.  Leptin 734 
  Ahima R. S., Flier J. S. (2000) 735 
  Annu. Rev. Physiol 62: 413-437. 736 
  DOI: 10.1146/annurev.physiol.62.1.413 737 
 2.  Age-period-cohort analyses of obesity prevalence in US adults 738 
  An R., Xiang X. (2016) 739 
  Public Health 141: 163-169. 740 
  DOI:10.1016/j.puhe.2016.09.021 741 
 3.  Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical 742 
processing in Rett syndrome. 743 
  Banerjee A., Rikhye R. V., Breton-Provencher V., Tang X., Li C., Li K., Runyan C. A., 744 
Fu Z., Jaenisch R., Sur M. (2016) 745 
  Proc. Natl. Acad. Sci. U. S A 113: 7284-7296. 746 
  DOI:10.1073/pnas.1615330113 747 
 4.  GABA: a pioneer transmitter that excites immature neurons and generates 748 
primitive oscillations 749 
  Ben Ari Y., Gaiarsa J. L., Tyzio R., Khazipov R. (2007) 750 
  Physiol Rev. 87: 1215-1284. 751 
  DOI:10.1152/physrev.00017.2006 752 
 5.  Refuting the challenges of the developmental shift of polarity of GABA actions: 753 
GABA more exciting than ever! 754 
  Ben-Ari Y., Woodin M. A., Sernagor E., Cancedda L., Vinay L., Rivera C., Legendre 755 
P., Luhmann H. J., Bordey A., Wenner P., Fukuda A., Van den Pol A. N., Gaiarsa J. L., 756 
Cherubini E. (2012) 757 
  Front Cell Neurosci. 6: 1-18. 758 
  DOI: 10.3389/fncel.2012.00035 759 
 6.  Characterization of GABAergic neurons in hippocampal cell cultures 760 
  Benson D. L., Watkins F. H., Steward O., Banker G. (1994) 761 
  J. Neurocytol. 23: 279-295 762 
 7.  Long-term plasma levels of leptin and adiponectin in Rett syndrome 763 
  Blardi P., de Lalla A., D'Ambrogio T., Vonella G., Ceccatelli L., Auteri A., Hayek J. 764 
(2009) 765 
  Clin. Endocrinol. (Oxf) 70: 706-709. 766 
  DOI:10.1111/j.1365-2265.2008.03386.x 767 
 8.  Neurodevelopmental actions of leptin 768 
  Bouret S. G. (2010) 769 
  Brain Res. 1350: 2-9. 770 
  DOI: 10.1016/j.brainres.2010.04.011 771 
 9.  Trophic action of leptin on hypothalamic neurons that regulate feeding 772 
  Bouret S. G., Draper S. J., Simerly R. B. (2004) 773 
 
38 
 
  Science 304: 108-110. 774 
  DOI: 10.1126/science.1095004 775 
 10.  Leptin in pregnancy and development: a contributor to adulthood disease? 776 
  Briffa J. F., McAinch A. J., Romano T., Wlodek M. E., Hryciw D. H. (2015) 777 
  Am J Physiol Endrocrinol Metab 308: 335-350. 778 
  Medline doi:10.1152/ajpendo.00312.2014 779 
 11.  Excitatory GABA action is essential for morphological maturation of cortical 780 
neurons in vivo 781 
  Cancedda L., Fiumelli H., Chen K., Poo M. M. (2007) 782 
  J. Neurosci. 27: 5224-5235. 783 
  DOI: 10.1523/JNEUROSCI.5169-06.2007 784 
 12.  A GABAergic projection from the zona incerta to cortex promotes cortical neuron 785 
development. 786 
  Chen J., Kriegstein A. (2015) 787 
  Science 350: 554-558. 788 
  DOI:10.1126/science.aac6472 789 
 13.  Early expression of KCC2 in rat hippocampal cultures augments expression of 790 
functional GABA synapses 791 
  Chudotvorova I., Ivanov A., Rama S., Hubner C. A., Pellegrino C., Ben Ari Y., Medina 792 
I. (2005) 793 
  J. Physiol 566: 671-679. 794 
  DOI: 10.1113/jphysiol.2005.089821 795 
 14.  Restoring GABAergic inhibition rescues memory deficitd in a Huntington's 796 
diseaqe mouse model 797 
  Dargaei Z., Bang J. Y., Mahadevan V., Khademullah C. S., Bedard S., Parfitt G. M., 798 
Kim J. C., Woodin M. A. (2018) 799 
  Proc. Natl. Acad. Sci. U. S A 115: 1618-1626. 800 
  DOI: 10.1073/pnas.1716871115 801 
 15.  Reversing excitatory GABAAR signaling restores synaptic plasticity and memory 802 
in a mouse model of Down syndrome 803 
  Deidda G., Parrini M., Naskar S., Bozarth I. F., Contestabile A., Cancedda L. (2015) 804 
  Nat. Med. 21: 318-326. 805 
  DOI:10.1038/nm.3827 806 
 16.  Leptin induces hippocampal synaptogenesis via CREB-regulated microRNA-132 807 
suppression of p250GAP 808 
  Dhar M., Zhu M., Impey S., Lambert T. J., Bland T., Karatsoreos I. N., Nakazawa T., 809 
Appleyard S. M., Wayman G. A. (2014) 810 
  Mol. Endocrinol. 28: 1073-1087. 811 
  DOI: 10.1210/me.2013-1332 812 
 17.  GABA and glutamate pathways are spatially and developmentally affected in the 813 
brain of Mecp2-deficient mice 814 
  El-Khoury R., Panayotis N., Matagne V., Ghata A., Villard L., Roux J. C. (2014) 815 
  PLoS. One. 9: e92169. 816 
 
39 
 
  DOI:10.1371/journal.pone.0092169 817 
 18.  Prevalence of obesity and trends in the distribution of body mass index among Us 818 
adults, 1999-2010 819 
  Flegal K. M., Carroll M. D., Kit B. L., Ogden C. L. (2012) 820 
  JAMA 307: 491-497. 821 
  DOI:10.1001/jama.2012.39 822 
 19.  Hypothyroidism impairs chloride homeostasis and onset of inhibitory 823 
neurotransmission in developing auditory brainstem and hippocampal neurons 824 
  Friauf E., Wenz M., Oberhofer M., Nothwang H. G., Balakrishnan V., Knipper M., 825 
Lohrke S. (2008) 826 
  Eur. J Neurosci. 28: 2371-2380. 827 
  DOI:10.1111/j.1460-9568.2008.06528.x 828 
 20.  WNK1-regulated inhibitory phosphorylation of the KCC2 cotransporter maintains 829 
the depolarizing action of GABA in immature neurons 830 
  Friedel P., Kahle K. T., Zhang J., Hertz N., Pisella L. I., Buhler E., Schaller F., Duan J., 831 
Khanna A. R., Bishop P. N., Shokat K. M., Medina I. (2015) 832 
  Sci. Signal. 8: ra65. 833 
  DOI:10.1126/scisignal.aaa0354 834 
 21.  Leptin potentiates GABAergic synaptic transmission in the developing rodent 835 
hippocampus 836 
  Guimond D., Diabira D., Porcher C., Bader F., Ferrand N., Zhu M., Appleyard S. M., 837 
Wayman G. A., Gaiarsa J. L. (2014) 838 
  Front Cell Neurosci. 8: 1-17. 839 
  DOI: 10.3389/fncel.2014.00235 840 
 22.  Leptin regulation of neuronal morphology and hippocampal synaptic function 841 
  Harvey J. (2013) 842 
  Front Synaptic. Neurosci. 5: 1-7. 843 
  DOI: 10.3389/fnsyn.2013.00003 844 
 23.  The developmental switch in GABA polarity is delayed in fragile X mice 845 
  He Q., Nomura T., Xu J., Contractor A. (2014) 846 
  J. Neurosci. 34: 446-450. 847 
  DOI:10.1523/JNEUROSCI.4447-13.2014 848 
 24.  Taurine inhibits K+-Cl- cotransporter KCC2 to regulate embryonic Cl- 849 
homeostasis via with-no-lysine (WNK) protein kinase signaling pathway 850 
  Inoue K., Furukawa T., Kumada T., Yamada J., Wang T., Inoue R., Fukuda A. (2012) 851 
  J. Biol. Chem. 287: 20839-20850. 852 
  DOI: 10.1074/jbc.M111.319418 853 
 25.  NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA 854 
receptor-mediated currents 855 
  Lee H. H., Deeb T. Z., Walker J. A., Davies P. A., Moss S. J. (2011) 856 
  Nat. Neurosci. 14: 736-743. 857 
  DOI: 10.1038/nn.2806 858 
 
40 
 
 26.  Effects of bumetanide on neurobehavioral function in children and adolescents 859 
with autism spectrum disorders 860 
  Lemonnier E., Villeneuve N., Soni S., Serret S., Rosier A., Roue M., Brosset P., 861 
Viellard M., Bernoux D., Rondeau S., Thummler S., Ravel D., Ben Ari Y. (2017) 862 
  Transl. Psychiatry 7. 863 
  Medline doi:10.1038/tp.2017.10 864 
 27.  The Timing of the Excitatory-to-Inhibitory GABA Switch Is Regulated by the 865 
Oxytocin Receptor via KCC2 866 
  Leonzino M., Busnelli M., Antonucci F., Verderio C., Mazzanti M., Chini B. (2016) 867 
  Cell Rep. 15: 96-103. 868 
  DOI:10.1016/j.celrep.2016.03.013 869 
 28.  Plasma levels of leptin and adiponectin in fragile X Syndrome. 870 
  Lisik M. Z., Gutmajester E., Sieron A. L. (2016) 871 
  NeuroImmunoModulation 23: 239-243. 872 
  DOI:10.1159/000452336 873 
 29.  Current view on the functional regulation of the neuronal K(+)-Cl(-) cotransporter 874 
KCC2 875 
  Medina I., Friedel P., Rivera C., Kahle K. T., Kourdougli N., Uvarov P., Pellegrino C. 876 
(2014) 877 
  Front Cell Neurosci. 8: 27. 878 
  DOI:10.3389/fncel.2014.00027 879 
 30.  Is there more to gaba than synaptic inhibition? 880 
  Owens D. F., Kriegstein A. R. (2002) 881 
  Nat. Rev. Neurosci. 3: 715-727. 882 
  DOI: 10.1038/nrn919 883 
 31.  The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal 884 
maturation 885 
  Rivera C., Voipio J., Payne J. A., Ruusuvuori E., Lahtinen H., Lamsa K., Pirvola U., 886 
Saarma M., Kaila K. (1999) 887 
  Nature 397: 251-255. 888 
  DOI:10.1038/16697 889 
 32.  The role of maternal obesity in the risk of neuropsychiatric disorders 890 
  Rivera H. M., Christiansen K. J., Sullivan E. L. (2015) 891 
  Front Neurosci. 9: 1-10. 892 
  DOI: 10.3389/fnins.2015.00194 893 
 33.  Changes in adipokine levels in autism spectrum disorders 894 
  Rodrigues D. H., Rocha N. P., Sousa L. F., Barbosa I. G., Kummer A., Teixeira A. L. 895 
(2014) 896 
  Neuropsychobiology 69: 6-10. 897 
  DOI:10.1159/000356234 898 
 34.  Simultaneous two-photon imaging of intracellular chloride concentration and pH 899 
in mouse pyramidal neurons in vivo 900 
 
41 
 
  Sato S. S., Artoni P., Landi S., Cozzolino O., Parra R., Pracucci E., Trovato F., 901 
Szczurkowska J., Luin S., Arosio D., Beltram F., Cancedda L., Kaila K., Ratto G. M. 902 
(2017) 903 
  Proc. Natl. Acad. Sci. U. S A 114: 8770-8779. 904 
  DOI: 10.1073/pnas.1702861114 905 
 35.  Thyroid hormone-dependent development of the GABAergic pre- and post-906 
synaptic components in the rat hippocampus 907 
  Sawano E., Takahashi M., Negishi T., Tashiro T. (2013) 908 
  Int. J Dev. Neurosci. 31: 751-761. 909 
  DOI:10.1016/j.ijdevneu.2013.09.007 910 
 36.  Developmental expression patterns of KCC2 and functionally associated molecules 911 
in the human brain. 912 
  Sedmak G., Jovanov-Milisevic N., Puskarjov M., Ulamec M., Kruslin B., Kaila K., 913 
Judas M. (2016) 914 
  Cereb. Cortex 26: 4574-4589. 915 
  DOI:10.1093/cercor/bhv218 916 
 37.  Role of leptin in pregnancy: Consequences of maternal obesity 917 
  Tessier D. R., Ferraro Z. M., Gruslin A. (2013) 918 
  Placenta 34: 205-211. 919 
  DOI:10.1016/j.placenta.2012.11.035 920 
 38.  Could tuning of the inhibitory tone involve graded changes in neuronal chloride 921 
transport? 922 
  Titz S., Sammler E. M., Hormuzdi S. G. (2015) 923 
  Neuropharmacol. 95: 321-331. 924 
  DOI: 10.1016/j.neuropharm.2015.03.026 925 
 39.  Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the 926 
fetal brain during delivery 927 
  Tyzio R., Cossart R., Khalilov I., Minlebaev M., Hubner C. A., Represa A., Ben-Ari Y., 928 
Khazipov R. (2006) 929 
  Science 314: 1788-1792. 930 
  DOI:10.1126/science.1133212 931 
 40.  Oxytocin-mediated GABA inhibition during delivery attenuates autism 932 
pathogenesis in rodent offspring 933 
  Tyzio R., Nardou R., Ferrari D. C., Tsintsadze T., Shahrokhi A., Eftekhari S., Khalilov 934 
I., Tsintsadze V., Brouchoud C., Chazal G., Lemonnier E., Lozovaya N., Burnashev N., 935 
Ben-Ari Y. (2014) 936 
  Science 343: 675-679. 937 
  DOI:10.1126/science.1247190 938 
 41.  The impact of leptin on perinatal development and psychopathology 939 
  Valleau J. C., Sullivan E. L. (2014) 940 
  J. Chem. Neuroanat. 61: 232. 941 
  DOI:10.1016/j.jchemneu.2014.05.001 942 
 42.  leptin resistance and hippocampal deficits 943 
 
42 
 
  Van Doorn C., Macht V. A., Grillo C. A., Reagan L. P. (2017) 944 
  Physiologyy and Behavior 176: 207-213. 945 
  DOI: 10.1016/j.physbeh.2017.03.002 946 
 43.  GABA regulates excitatory synapse formation in the neocortex via NMDA receptor 947 
activation 948 
  Wang D. D., Kriegstein A. R. (2008) 949 
  J. Neurosci. 28: 5547-5558 950 
 44.  Blocking early GABA depolarization with bumetanide results in permanent 951 
alterations in cortical circuits and sensorimotor gating deficits 952 
  Wang D. D., Kriegstein A. R. (2011) 953 
  Cereb. Cortex 21: 574-587. 954 
  DOI: 10.1093/cercor/bhq124 955 
 45.  Maternal body mass index and risk of autism spectrum disorders in offspring: A 956 
meta-analysis 957 
  Wang Y., Tang S., Xu S., Weng S., Liu Z. (2016) 958 
  Sci. Rep. 6: 1-8. 959 
  DOI: 10.1038/srep34248 960 
 961 
 962 


KCC2
db WT ladder (-) db WT ladder (-)
Tubulin



